CRIS FY 2022 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-4.6% YoY

Gross Profit

$10M97.5% margin

Operating Income

-$53M-521.7% margin

Net Income

-$57M-557.7% margin

EPS (Diluted)

$-12.14

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$55M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$109M

Total Liabilities

$62M

Stockholders' Equity

$47M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$11M	-4.6%
Gross Profit	$10M	$10M	-2.1%
Operating Income	-$53M	-$42M	-26.0%
Net Income	-$57M	-$45M	-24.7%